TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE – Trademark Portfolio
Entity Type: 99
TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include THE TAX-EXEMPT FUND OF CALIFORNIA. The owner is based in LOS ANGELES, CA.
333 SOUTH HOPE STREET
LOS ANGELES, CA 90071
Showing of trademarks Trademarks
Trademark Classifications
TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE have?
TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE file in?
TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE's most well-known trademarks?
TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE's registered trademark portfolio includes well-known marks such as THE TAX-EXEMPT FUND OF CALIFORNIA. These are among 1 currently registered trademark in the portfolio.
What is TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE's trademark registration success rate?
TRUSTEES OF THE AMERICAN FUNDS TAX-EXEMPT SERIES II, THE has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.